CordenPharma has acquired Ancora Pharmaceuticals based in Woburn, MA. Ancora offers a carbohydrate synthesis technology platform from its chemistry research facilities. The acquisition enhances CordenPharma’s capabilities in the manufacture and supply of complex synthetic molecules. Ancora’s expertise in carbohydrate synthes will be merged with CordenPharma’s process development, scale-up and cGMP manufacturing capabilities to supply synthetic carbohydrates for all applications, including glyco...